Myasthenia gravis trials in United States

In United States 52 Also abroad 123

52 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
AXIS MG Patient Registry
Where
Framingham
Age
18 years and over
People
1,000
Run by
Autoimmune Neurology Alliance
See details and how to joinNCT07761026
No phaseTaking people
Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA)
Where
San Francisco
Age
18 years to 64 years
People
250
Run by
University of California, San Francisco
See details and how to joinNCT06940323
No phaseTaking people
MuSK Myasthenia 1000 Study
Where
Washington D.C.
Age
7 years to 99 years
People
1,000
Run by
George Washington University
See details and how to joinNCT06259071
Phase 1/2Taking people
Study of Aritinercept in Patients With Generalized Myasthenia Gravis
Where
Altamonte Springs, Boca Raton, Chicago, Dearborn, Flint, Homestead, Houston, Miami, O'Fallon, Pasadena
Age
18 years to 85 years
People
81
Run by
Aurinia Pharmaceuticals Inc.
See details and how to joinNCT07596901
Phase 3Taking people
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Where
Atlanta, Augusta, Carlsbad, Chapel Hill, Charleston, Charlottesville, Cincinnati, Clearwater, Dallas, Denton, Detroit, Durham, East Lansing, Eugene, Fort Collins, Foxborough, Greenfield, Houston, Huntsville, Irvine, Lexington, Los Angeles, Lubbock, Memphis, Mobile, New Haven, New Orleans, New York, Nicholasville, Oklahoma City, Omaha, Ormond Beach, Phoenix, Port Charlotte, Raleigh, Rancho Mirage, Richmond, Rockledge, San Francisco, Schaumburg, Scottsdale, Tampa, Totowa, Tucson, Washington D.C., Yukon
Age
18 years to 80 years
People
231 worldwide
Run by
Immunovant Sciences GmbH
See details and how to joinNCT07039916 · EU 2024-515979-35-00
Phase 2/3Taking people
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
Where
Columbia, Houston, Indianapolis, Los Angeles, Miami, Murray, Orange, Palo Alto, Philadelphia, Portland
Age
18 years to 75 years
People
66 worldwide
Run by
Kyverna Therapeutics
See details and how to joinNCT06193889 · EU 2023-509892-17-00
Phase 1/2Taking people
Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders
Where
Cincinnati, St Louis, Washington D.C.
Age
12 years and over
People
50
Run by
Cartesian Therapeutics
See details and how to joinNCT07089121
No phaseEnrolling by invitation
Serum Auto-Antibodies in Neurological Diseases
Where
Sacramento
Age
18 years and over
People
120
Run by
University of California, Davis
See details and how to joinNCT00704626
No phaseTaking people
Study of Ultomiris® (Ravulizumab) Safety in Pregnancy
Where
Boston
People
75 worldwide
Run by
Alexion Pharmaceuticals, Inc.
See details and how to joinNCT06312644
Phase 4Taking people
A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab
Where
Chicago, Knoxville, Neptune City, Raleigh, Schaumburg
Age
18 years and over
People
75 worldwide
Run by
Alexion Pharmaceuticals, Inc.
See details and how to joinNCT07221838 · EU 2025-522555-26-00
Phase 3Taking people
PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis
Where
Norfolk, Washington D.C.
Age
6 years to 17 years
People
12 worldwide
Run by
Alexion Pharmaceuticals, Inc.
See details and how to joinNCT06607627 · EU 2024-515157-17-00
No phaseTaking people
Light vs. Moderate Intensity Exercise in Individuals With Myasthenia Gravis
Where
Saint Paul
Age
18 years to 80 years
People
20
Run by
HealthPartners Institute
See details and how to joinNCT06491238
Phase 4Taking people
A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG)
Where
Atlanta, Boca Raton, Chattanooga, Cleveland, Detroit, Greenfield, Honolulu, Jacksonville, La Jolla, Miami, O'Fallon, Orange, Port Charlotte, Rancho Mirage, Round Rock, St. Petersburg, Worcester
Age
18 years and over
People
30
Run by
argenx
See details and how to joinNCT06909214
No phaseTaking people
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Where
Augusta, Birmingham, Boston, Burlington, Chapel Hill, Charlotte, Chattanooga, Clearwater, Colorado Springs, Columbia, Dallas, Dayton, Durham, Fort Collins, Fresno, Gainesville, Houston, Iowa City, Jacksonville, Knoxville, Lansing, Lexington, Milwaukee, New Haven, New Hyde Park, Orange, Philadelphia, Rancho Mirage, Scottsdale, Sylmar, Tampa, Washington D.C.
Age
18 years and over
People
500 worldwide
Run by
Alexion Pharmaceuticals, Inc.
See details and how to joinNCT04202341
No phaseTaking people
A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
Where
Austin, Boca Raton, Boston, Charleston, Detroit, Greenfield, Iowa City, Jacksonville Beach, Kansas City, Louisville, O'Fallon, Port Charlotte, Portland, San Francisco, St. Petersburg
Age
18 years and over
People
680 worldwide
Run by
argenx
See details and how to joinNCT06298565
No phaseTaking people
A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
Where
Morgantown
People
279 worldwide
Run by
argenx
See details and how to joinNCT06299748
Phase 1/2Taking people
A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis
Where
Altamonte Springs, Boca Raton, Houston, Kansas City, Naples, Port Charlotte, Tampa
Age
18 years to 74 years
People
96 worldwide
Run by
ImmunAbs Inc.
See details and how to joinNCT07250750 · EU 2025-522406-20-00
Phase 2/3Taking people
A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
Where
Denver
Age
18 years and over
People
70 worldwide
Run by
Kyverna Therapeutics
See details and how to joinNCT07403188 · EU 2024-511198-31-00
No phaseTaking people
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Where
Delafield
Age
2 years and over
People
10,000
Run by
Brain Inflammation Collaborative
See details and how to joinNCT04806620
No phaseTaking people
The EXPLORE MG Registry for Myasthenia Gravis
Where
New Haven
Age
18 years and over
People
800
Run by
Yale University
See details and how to joinNCT03792659
No phaseNot yet taking people in United States
Multi-Modal Monitoring of Disease Symptoms in Myasthenia Gravis
Where
Boston
Age
18 years to 80 years
People
50
Run by
BioSensics
See details and how to joinNCT07224386
No phaseTaking people
Vitaccess Real MG Registry
Where
Charleston, Houston, Lexington, Lumberton, O'Fallon, Orange
Age
18 years and over
People
600 worldwide
Run by
Vitaccess Ltd
See details and how to joinNCT06064461
Phase 4Taking people
Treatment of Myasthenia Gravis Exacerbation or Crisis With Efgartigimod
Where
Aurora
Age
18 years and over
People
20
Run by
University of Colorado, Denver
See details and how to joinNCT06860633
No phaseTaking people
The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis
Where
Aurora, Bloomington, Durham, Indianapolis, Jacksonville, Knoxville, Lake Success, Lexington, Nashville, Philadelphia, Portland
Age
18 years and over
People
144 worldwide
Run by
Ad scientiam
See details and how to joinNCT05564936
No phaseTaking people
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Myasthenia Gravis
Where
Columbia, Fairway
Age
18 years and over
People
16
Run by
University of Missouri-Columbia
See details and how to joinNCT06064695